THE AFRICA TIMES | EGYPT — Takeda, a global biopharmaceutical company focused on patient care, has successfully concluded the second Eurasia, Middle East, and Africa (EAMEA) Hereditary Angioedema (HAE) Summit in Cairo. This event brought together specialists to advance the management of this rare and potentially life-threatening disease.
The scientific meeting took place at the Sofitel Nile Hotel in Cairo. It gathered healthcare experts involved in treating HAE, aiming to strengthen scientific exchange and peer learning around best clinical practices.
Summit Highlights
Organized under the theme “Reimagine The Way You Treat Your HAE,” the summit featured national and international experts from multiple specialties. These included internal medicine, pediatrics, immunology, pulmonology, allergy, and pharmacology.
Participants shared valuable clinical insights, emerging evidence, and real-world experiences in managing hereditary
